v3.26.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Nonvested Restricted Shares
A summary of changes in the Company’s nonvested restricted shares for the year ended December 31, 2025 and December 31, 2024 follows:
SharesWeighted-Average
Grant-Date
Fair Value, per share
Nonvested at January 1, 2025
47,485 $14.54 
Granted
25,800 15.78 
Vested
(25,380)(13.38)
Forfeited
(14,155)(15.66)
Nonvested at December 31, 2025
33,750 $15.87 
SharesWeighted-Average
Grant-Date
Fair Value, per share
Nonvested at January 1, 2024
52,195 $18.75 
Granted
30,650 11.70 
Vested
(34,235)(18.36)
Forfeited
(1,125)(16.05)
Nonvested at December 31, 2024
47,485 $14.54 
Schedule of Activity in the Equity Plan
A summary of the activity in the Equity Plan for the year ended December 31, 2025 and December 31, 2024 follows:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (in years)
Aggregate
Intrinsic
Value
Outstanding at January 1, 2025
364,063 $15.68 
Exercised
(1,050)(14.67)
Forfeited
(3,780)(15.14)
Outstanding at December 31, 2025
359,233 $15.68 3.54$— 
Vested and exercisable at December 31, 2025
356,143 $15.69 3.53$— 
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (in years)
Aggregate
Intrinsic
Value
Outstanding at January 1, 2024
367,033 $15.68 
Forfeited
(2,970)(15.52)
Outstanding at December 31, 2024
364,063 $15.68 4.65$— 
Vested and exercisable at December 31, 2024
349,385 $15.71 4.61$—